论文部分内容阅读
采用放射免疫法测定30例脑梗塞患者血浆内血小板α颗粒膜蛋白140(GMP140)和血栓烷B2(TXB2)浓度。结果显示:脑梗塞患者血浆GMP140浓度在急性期显著增高,恢复期降至正常;血浆TXB2浓度在急性期和恢复期均显著增高;正常人血浆GMP140和TXB2浓度与年龄均呈显著正相关;脑梗塞患者急性期血浆GMP140、TXB2浓度与患者年龄、梗塞灶体积及神经功能缺损评分均呈正相关。提示:(1)脑梗塞患者急性期血小板高度活化,为选用抗血小板药物治疗提供了客观依据;检测血浆GMP140、TXB2浓度对病情监护、预后评估具有一定参考价值。(2)年龄是影响血小板功能的一个重要因素
Plasma platelet α-granule membrane protein 140 (GMP140) and thromboxane B2 (TXB2) concentrations were measured in 30 patients with cerebral infarction by radioimmunoassay. The results showed that: plasma concentrations of GMP 140 in patients with acute cerebral infarction were significantly increased in the recovery period to normal; plasma TXB2 concentrations were significantly increased in acute and convalescent; normal plasma GMP 140 and TXB2 concentrations and age were significant Positive correlation; acute phase of patients with cerebral infarction in plasma GMP 140, TXB2 concentration and patient age, infarct volume and neurological deficit scores were positively correlated. Tip: (1) Acute phase of platelet activation in patients with acute cerebral infarction provides an objective basis for the selection of anti-platelet drug therapy; detection of plasma GMP 140, TXB2 concentration of the disease monitoring, prognosis evaluation of a certain reference value. (2) Age is an important factor affecting platelet function